Targeted degradation of BRD4 by PROTACs: advances in cancer therapy
Chemical Communications · 2026 · 62 (17) · 4869-4888
DOI: 10.1039/d5cc05563f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Yanyun Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 33001…. Hauptthemen laut MEDLINE: Neoplasms, Transcription Factors, Cell Cycle Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, Jiangxi Science and Technology Normal University.
Abstract (Originalsprache)
This schematic illustrates the multidimensional optimization strategies for BRD4-targeting PROTACs, encompassing the rational design of the ternary complex, diverse controllable activation systems, and targeted delivery approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, Jiangxi, China. shanxu9891@126.com.
- East China University of Science and Technology, Shanghai, China.
Förderung
- Natural Science Foundation of Jiangxi Province
- Jiangxi Science and Technology Normal University
Zitieren
APA
Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869-4888. https://doi.org/10.1039/d5cc05563f
Vancouver
Hong Y, Liu X, Li Y, Yu M, Wang C, Nie C, et al. Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications. 2026;62(17):4869-4888. doi:10.1039/d5cc05563f
BibTeX
@article{Hong2026,
author = {Hong, Yanyun and Liu, Xiang and Li, Yinglong and Yu, Mengting and Wang, Caolin and Nie, Cunpeng and Xu, Shan},
title = {Targeted degradation of BRD4 by PROTACs: advances in cancer therapy},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {17},
pages = {4869--4888},
doi = {10.1039/d5cc05563f}
}
EUVIMED